Geisinger to Test Vocal Biomarker Algorithm to Detect COPD Exacerbations

Geisinger is launching a new study to test if a novel technique can detect flare-ups or exacerbations experienced by patients with chronic obstructive pulmonary disease (COPD) by listening to their voices through their smart phones.

These flare-ups and exacerbations are typically caused by an infection in the lungs, which can cause inflammation and narrow the airway.

Using Healthyzime’s vocal biomarker algorithm, the Voice Analysis of COPD Patients with Exacerbations (VOICE) study will use personalized, artificial intelligence-based vocal biomarkers that will allow clinicians to monitor patients through their smart phones.